Referenser

  1. Östman J, Agenäs I, Brun J, Elwin CE, Engstrand L, Johansson S, Lindberg G, Marké L-Å, Norlund A, Nyrén O, Seensalu R, Sjölund K, Svensson Å, Wallmark J, Werkö L. . Ont i magen – metoder för diagnos och behandling av dyspepsi. Stockholm; 2000. Report No.: SBU rapport 150.

  2. Weusten B, Bisschops R, Dinis-Ribeiro M, di Pietro M, Pech O, Spaander MCW, et al. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2023;55(12):1124-46.

  3. Kröner PT, Cortés P, Lukens FJ. The Medical Management of Gastroesophageal Reflux Disease: A Narrative Review. J Prim Care Community Health. 2021;12:21501327211046736.

  4. DeMeester SR. Laparoscopic Hernia Repair and Fundoplication for Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am. 2020;30(2):309-24.

  5. Spergel J, Aceves SS. Allergic components of eosinophilic esophagitis. J Allergy Clin Immunol. 2018;142(1):1-8.

  6. Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155(4):1022-33.e10.

  7. Carlson M, Dlugosz A, Andersson S, Janson C, Käppi T, Larsson H, Thulin H, Truskaite K, Wanders A. Utredning och behandling av eosinofil esofagit - Nationell riktlinje: Svenska gastroenterologisk förening; 2020 [Available from: https://svenskgastroenterologi.se/kunskap/utredning-och-behandlingav-esosinofil-esofagit/

  8. Käppi T., Guallarte P., Nilsson C., Thulin H., van der Pals M. ZC, Jansson Roth A.  Vårdprogrammet för eosinofil esofagit hos barn och ungdomar 2020 [Available from: https://gastro.barnlakarforeningen.se/wp-content/uploads/sites/10/2020/10/EoE-va%CC%8Ardprogram-201009.pdf

  9. Molina-Infante J, Arias Á, Alcedo J, Garcia-Romero R, Casabona-Frances S, Prieto-Garcia A, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study. J Allergy Clin Immunol. 2018;141(4):1365-72.

  10. Kagalwalla AF, Wechsler JB, Amsden K, Schwartz S, Makhija M, Olive A, et al. Efficacy of a 4-Food Elimination Diet for Children With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2017;15(11):1698-707.e7.

  11. Arias A, González-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146(7):1639-48.

  12. Kliewer KL, Cassin AM, Venter C. Dietary Therapy for Eosinophilic Esophagitis: Elimination and Reintroduction. Clin Rev Allergy Immunol. 2018;55(1):70-87.

  13. Jeremiasen M, Linder G, Hedberg J, Lundell L, Björ O, Lindblad M, et al. Improvements in esophageal and gastric cancer care in Sweden-population-based results 2007-2016 from a national quality register. Dis Esophagus. 2020;33(3).

  14. Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010-21.

  15. Robinson K, Atherton JC. The Spectrum of Helicobacter-Mediated Diseases. Annu Rev Pathol. 2021;16:123-44.

  16. Agréus L, Hellström PM, Talley NJ, Wallner B, Forsberg A, Vieth M, et al. Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community. United European Gastroenterol J. 2016;4(5):686-96.

  17. Song H, Held M, Sandin S, Rautelin H, Eliasson M, Söderberg S, et al. Increase in the Prevalence of Atrophic Gastritis Among Adults Age 35 to 44 Years Old in Northern Sweden Between 1990 and 2009. Clin Gastroenterol Hepatol. 2015;13(9):1592-600.e1.

  18. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017;153(2):420-9.

  19. Resina E, Donday MG, Martínez-Domínguez SJ, Laserna-Mendieta EJ, Lanas Á, Lucendo AJ, et al. Evaluation of a New Monoclonal Chemiluminescent Immunoassay Stool Antigen Test for the Diagnosis of Helicobacter pylori Infection: A Spanish Multicentre Study. J Clin Med. 2022;11(17).

  20. Ferwana M, Abdulmajeed I, Alhajiahmed A, Madani W, Firwana B, Hasan R, et al. Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis. World J Gastroenterol. 2015;21(4):1305-14.

  21. Hu Y, Zhang M, Lu B, Dai J. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem. Helicobacter. 2016;21(5):349-63.

  22. Agreus L., Lööf L., Simrén M., Ekesbo R., Seensalu R., Ehnberg A., Engstrand L., Staël von Holstein C., . Nationell riktlinje 2019 - Outredd dyspepsi, okomplicerade duodenal- och ventrikelsår samt funktionell dyspepsi 2019 [Available from: https://svenskgastroenterologi.se/wp-content/uploads/2022/09/outredd_dyspepsi_ulkus_samt_funktionell_dyspepsi_2019.pdf

  23. Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022.

  24. Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with peptic ulcer disease. Am J Med. 2010;123(4):358-66.e2.

  25. Talley NJ, Silverstein MD, Agréus L, Nyrén O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology. 1998;114(3):582-95.

  26. Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. Bmj. 2013;347:f4587.

  27. Aro P, Ronkainen J, Storskrubb T, Vieth M, Engstrand L, Johansson SE, et al. Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Eur J Epidemiol. 2010;25(10):741-50.

  28. Lazzaroni M, Bianchi Porro G. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Aliment Pharmacol Ther. 2004;20 Suppl 2:48-58.

  29. Casswall T, Arnell H. Uppdaterade riktlinjer för handläggning av barn med Helocibacter pylori-infektion. Strategin >testa och behandla< rekommenderas inte för barn. Läkartidningen. 2018;115.

  30. van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):209-24.

  31. Gralnek IM, Stanley AJ, Morris AJ, Camus M, Lau J, Lanas A, et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021. Endoscopy. 2021;53(3):300-32.

  32. Seensalu R., Höög A., Wurm Johansson G., Bednarska O., Lindblad M., Omae M., Ye W.,. Nationell riktlinje - Handläggning och uppföljning av kronisk atrofisk gastrit, intestinal metaplasi och dysplasi i ventrikeln 2022 [Available from: https://svenskgastroenterologi.se/wp-content/uploads/2022/10/2022-kronisk-atrofisk-gastrit-intestinal-metaplasi-och-dysplasi-i-ventrikeln.pdf

  33. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635-48.

  34. Hermansson M., Szabo E., Borg D., Dzhendov T., Hedberg J., Lagergren P., Lindberg F, Motacki N, Sunde B., von Platen D., Magnusson B., Lin Burström L.. Nationellt vårdprogram - Matstrups- och magsäckscancer 2022 [Available from: https://kunskapsbanken.cancercentrum.se/globalassets/cancerdiagnoser/matstrupe-och-magsack/vardprogram/nationellt-vardprogram-matstrups-magsackscancer.pdf

  35. Rosenstock S, Kay L, Rosenstock C, Andersen LP, Bonnevie O, Jørgensen T. Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut. 1997;41(2):169-76.

  36. Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150(6):1380-92.

  37. Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257-61.

  38. Aro P, Talley NJ, Johansson SE, Agréus L, Ronkainen J. Anxiety Is Linked to New-Onset Dyspepsia in the Swedish Population: A 10-Year Follow-up Study. Gastroenterology. 2015;148(5):928-37.

  39. Duncanson KR, Talley NJ, Walker MM, Burrows TL. Food and functional dyspepsia: a systematic review. J Hum Nutr Diet. 2018;31(3):390-407.

  40. Strand M, von Hausswolff-Juhlin Y, Welch E. ARFID: restriktivt ätande utan rädsla för viktuppgång. Läkartidningen. 2018;115.

  41. Lu Y, Chen M, Huang Z, Tang C. Antidepressants in the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(6):e0157798.

  42. Olausson EA, Störsrud S, Grundin H, Isaksson M, Attvall S, Simrén M. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol. 2014;109(3):375-85.

  43. Lehmann S, Ferrie S, Carey S. Nutrition Management in Patients With Chronic Gastrointestinal Motility Disorders: A Systematic Literature Review. Nutr Clin Pract. 2020;35(2):219-30.

  44. El Halabi M, Parkman HP. 2023 update on the clinical management of gastroparesis. Expert Rev Gastroenterol Hepatol. 2023;17(5):431-41.

  45. Fonseca Mora MC, Milla Matute CA, Alemán R, Castillo M, Giambartolomei G, Schneider A, et al. Medical and surgical management of gastroparesis: a systematic review. Surg Obes Relat Dis. 2021;17(4):799-814.

  46. EMA. EMA confirms recommendation to suspend all ranitidine medicines in the EU Amsterdam: European Medicines Agency; 2020 [Available from: https://www.ema.europa.eu/en/documents/referral/ranitidine-article-31-referral-ema-confirms-recommendation-suspend-all-ranitidine-medicines-eu_en.pdf

  47. Agréus L, Borgquist L., Tsoposidis A., Wallenius V., Kostic S., Lundell L., Lindberg G., . Stor överförskrivning och ökat bruk av protonpumpshämmare. Läkartidningen. 2021;118(20220).

  48. Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990;322(15):1028-31.

Föregående sida
Läkemedel

Nästa sida
Tillbaka till kapitlets första sida